BMJ Global Health is an open access, online journal from BMJ dedicated to publishing high-quality peer-reviewed content relevant to those involved in global health, including policy makers, funders, researchers, clinicians and frontline healthcare workers.

To find out more about the journal’s vision, please read the introductory editorial from the journal’s Editor-in-Chief, Dr Seye Abimbola.

Aims and scope

The Journal covers all aspects of global health with particular interest in submissions that address the underfunded area of non-communicable diseases (NCDs). Research across all study phases and designs is welcome, from study protocols to phase I trials to meta-analyses, including small or specialist studies. The editor welcomes opinionated discussions on controversial topics to stimulate debate.

BMJ Global Health will adhere to BMJ’s rigorous standards of peer-review and all papers will be considered on the basis of ethical and methodological soundness rather than their novelty, significance, or relevance to any particular group. The Journal will operate a fast submission process with continuous publication online to ensure that timely, up-to-date research is available worldwide to those who need it.


BMJ Global Health is owned by BMJ.

Editorial board

For information about the BMJ Global Health editorial team, please refer to the Editorial Board page.

Journal information

Publication Model Open access
Frequency Continuous online publication
Launch date 2016
Digital archive LOCKSS
Indexed by Web of Science Core Collection: Emerging Sources Citation Index, PubMed Central, Scopus, DOAJ, Google Scholar, Scopus
Peer review model Single blind; the names of reviewers are hidden from the author
Online ISSN 2059-7908

Journal statistics (2018)

Acceptance Rate 41%
Time from Acceptance to Publication 23 days


Dryad logo

Dryad is an international repository of data underlying peer-reviewed articles in the basic and applied biosciences. Dryad enables scientists to validate published findings, explore new analysis methodologies, repurpose data for research questions unanticipated by the original authors, and perform synthetic studies. BMJ has been working with Dryad since 2010.

COPE logo

The BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.


The mission of OASPA is to support and represent the interests of open access journal publishers globally in all scientific, technical, and scholarly disciplines. The BMJ Publishing Group has been a member since 2009.


Open Access articles in BMJ Global Health are licensed using either Creative Commons Attribution (CC BY) or Attribution Non-Commercial (CC BY-NC) license. These licenses let others distribute, remix, tweak and build upon your work.

AllTrials logo

BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.